Table IV.

Clinical outcomes of initiated stimulation cycles by presence of SEOA.

Result of Cycle	With SEOA (N = 301)	Without SEOA (N = 643)	Crude OR	P	Adjusteda OR	P
Cycle cancelled	18.9% (57)	13.5% (87)	1.5 (1.0–2.2)	0.03	1.0 (0.7–1.6)	0.87
No eggs collected	0.7% (2)	1.1% (7)	0.6 (0.1–2.9)	0.54	0.4 (0.1–2.1)	0.28
No embryo transferred	56.8% (171)	47.9%% (308)	1.4 (1.1–1.9)	0.01	1.3 (1.0–1.8)	0.06
Freeze-all embryos cycle	19.6% (59)	20.2% (130)	1.0 (0.7–1.4)	0.83	1.2 (0.8–1.7)	0.35
No clinical pregnancy from ET	33.2% (100)	34.8% (224)	0.9 (0.7–1.2)	0.63	1.0 (0.7–1.3)	0.79
Clinical pregnancy	10.0% (30)	17.3% (111)	0.5 (0.4–0.8)	<0.01	0.6 (0.4–1.0)	0.03
Clinical pregnancy loss	5.0% (15)	8.4% (54)	0.6 (0.3–1.0)	0.06	0.6 (0.3–1.1)	0.12
Live birth	5.0% (15)	8.9% (57)	0.5 (0.3–1.0)	0.04	0.6 (0.3–1.2)	0.15

^a Logistic Regression prediction model included explanatory variables: age, smoking status, treatment cycle, aetiology status (endometriosis, ovulation defect, polycystic ovaries, polycystic ovarian syndrome), parity status. This analysis used pooled results from multiple imputation data. OR: odds ratio.

Data presented as % (n).